Diabetes: Personalised therapy reduces the risk of cardiovascular disease

heart

Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of diabetics who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy.

Read more

Posted in Medical Research